No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr14:71277200-71288000 |
Weak transcription |
Primary T cells effector/memory enriched fromperipheralblood |
blood
|
2 |
chr14:71277200-71288400 |
Weak transcription |
Pancreas |
Pancrea
|
3 |
chr14:71277800-71288000 |
Weak transcription |
Brain Dorsolateral Prefrontal Cortex |
brain
|
4 |
chr14:71279400-71288000 |
Weak transcription |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
5 |
chr14:71282800-71288400 |
Weak transcription |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
6 |
chr14:71284400-71288000 |
Weak transcription |
Psoas Muscle |
Psoas
|
7 |
chr14:71284400-71288200 |
Weak transcription |
H1 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
8 |
chr14:71284400-71288200 |
Weak transcription |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
9 |
chr14:71284800-71288000 |
Weak transcription |
A549 |
lung
|
10 |
chr14:71284800-71288200 |
Weak transcription |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
11 |
chr14:71285000-71288200 |
Weak transcription |
GM12878-XiMat |
blood
|
12 |
chr14:71285000-71288800 |
Weak transcription |
Hela-S3 |
cervix
|
13 |
chr14:71285200-71288000 |
Weak transcription |
Primary T helper naive cells from peripheral blood |
blood
|
14 |
chr14:71287400-71288200 |
Enhancers |
Osteobl |
bone
|
15 |
chr14:71287600-71288000 |
Bivalent Enhancer |
iPS-18 Cell Line |
embryonic stem cell
|
16 |
chr14:71287600-71288000 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
17 |
chr14:71287600-71288000 |
Bivalent Enhancer |
Fetal Intestine Large |
intestine
|
18 |
chr14:71287600-71288200 |
Bivalent Enhancer |
H1 BMP4 Derived Mesendoderm Cultured Cells |
ES cell derived
|
19 |
chr14:71287600-71288200 |
Enhancers |
ES-UCSF4 Cell Line |
embryonic stem cell
|
20 |
chr14:71287600-71288200 |
Enhancers |
HMEC |
breast
|
21 |
chr14:71287800-71288000 |
Flanking Bivalent TSS/Enh |
H1 Cell Line |
embryonic stem cell
|
22 |
chr14:71287800-71288000 |
Bivalent Enhancer |
H9 Derived Neuron Cultured Cells |
ES cell derived
|
23 |
chr14:71287800-71288000 |
Flanking Bivalent TSS/Enh |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
24 |
chr14:71287800-71288000 |
Bivalent Enhancer |
HUES6 Cell Line |
embryonic stem cell
|
25 |
chr14:71287800-71288000 |
Flanking Bivalent TSS/Enh |
HUES64 Cell Line |
embryonic stem cell
|
26 |
chr14:71287800-71288000 |
Flanking Bivalent TSS/Enh |
iPS-15b Cell Line |
embryonic stem cell
|
27 |
chr14:71287800-71288000 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
28 |
chr14:71287800-71288000 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
29 |
chr14:71287800-71288000 |
Enhancers |
Primary T helper cells PMA-I stimulated |
--
|
30 |
chr14:71287800-71288000 |
Bivalent Enhancer |
Primary T helper cells fromperipheralblood |
blood
|
31 |
chr14:71287800-71288000 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
32 |
chr14:71287800-71288000 |
Enhancers |
Liver |
Liver
|
33 |
chr14:71287800-71288000 |
Bivalent/Poised TSS |
Dnd41 |
blood
|
34 |
chr14:71287800-71288000 |
Enhancers |
HSMM |
muscle
|
35 |
chr14:71287800-71288200 |
Flanking Bivalent TSS/Enh |
iPS-20b Cell Line |
embryonic stem cell
|
36 |
chr14:71287800-71288200 |
Bivalent Enhancer |
Primary neutrophils fromperipheralblood |
blood
|
37 |
chr14:71287800-71288200 |
Enhancers |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
38 |
chr14:71287800-71288200 |
Enhancers |
NHEK |
skin
|
39 |
chr14:71287800-71288400 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|
40 |
chr14:71287800-71288400 |
Flanking Bivalent TSS/Enh |
Fetal Intestine Small |
intestine
|
41 |
chr14:71287800-71289800 |
Bivalent/Poised TSS |
ES-I3 Cell Line |
embryonic stem cell
|